Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–67.
Google Scholar
Gomez Garcia EB, Knoers NV. Gardner’s syndrome (familial adenomatous polyposis): a cilia-related disorder. Lancet Oncol. 2009;10:727–35.
Google Scholar
Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol. 2011;6:479–507.
Google Scholar
Vermeulen L, Morrissey E, van der Heijden M, Nicholson AM, Sottoriva A, Buczacki S, et al. Defining stem cell dynamics in models of intestinal tumor initiation. Science. 2013;342:995–8.
Google Scholar
Flanagan DJ, Pentinmikko N, Luopajarvi K, Willis NJ, Gilroy K, Raven AP, et al. NOTUM from Apc-mutant cells biases clonal competition to initiate cancer. Nature. 2021;594:430–5.
Google Scholar
van Neerven SM, de Groot NE, Nijman LE, Scicluna BP, van Driel MS, Lecca MC, et al. Apc-mutant cells act as supercompetitors in intestinal tumour initiation. Nature. 2021;594:436–41.
Google Scholar
van der Heijden M, Zimberlin CD, Nicholson AM, Colak S, Kemp R, Meijer SL, et al. Bcl-2 is a critical mediator of intestinal transformation. Nat Commun. 2016;7:10916.
Google Scholar
Ramesh P, Lannagan TRM, Jackstadt R, Atencia Taboada L, Lansu N, Wirapati P, et al. BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer. Cell Death Differ. 2021;28:3282–96.
Google Scholar
Zhang L, Ramesh P, Atencia Taboada L, Roessler R, Zijlmans DW, Vermeulen M, Picavet-Havik DI, et al. UGT8 mediated sulfatide synthesis modulates BAX localization and dictates apoptosis sensitivity of colorectal cancer. Cell Death Differ. 2024;32;657–71.
Wouters VM, Helderman R, Cameron K, van der Hooff SR, Torang A, van den Bergh S, et al. CDX2 downregulation regulates intrinsic WNT pathway activation, dictating metastasis in APC and CTNNB1 wildtype colorectal cancer. Oncogene. 2025;44;2091–2102.
Jackstadt R, van Hooff SR, Leach JD, Cortes-Lavaud X, Lohuis JO, Ridgway RA, et al. Epithelial NOTCH signaling rewires the tumor microenvironment of colorectal cancer to drive poor-prognosis subtypes and metastasis. Cancer Cell. 2019;36:319–36.e7.
Google Scholar
Drost J, van Jaarsveld RH, Ponsioen B, Zimberlin C, van Boxtel R, Buijs A, et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature. 2015;521:43–7.
Google Scholar
Vermeulen L, Melo FDSE, van der Heijden M, Cameron K, de Jong JH, Borovski T, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nature Cell Biol. 2010;12:468–U121.
Google Scholar
Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature. 2003;423:409–14.
Google Scholar
van Neerven SM, Ramadan R, van Driel MS, Huels DJ, Vermeulen L. Intestinal organoid co-culture protocol to study cell competition in vitro. STAR Protoc. 2022;3:101050.
Google Scholar
Ianevski A, He L, Aittokallio T, Tang J. SynergyFinder: a web application for analyzing drug combination dose-response matrix data. Bioinformatics. 2017;33:2413–5.
Google Scholar
Ramesh P, Di Franco S, Atencia Taboada L, Zhang L, Nicotra A, Stassi G, et al. BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal cancer. Cell Rep. 2022;38:110374.
Google Scholar
Colak S, Medema JP. Human colonic fibroblasts regulate stemness and chemotherapy resistance of colon cancer stem cells. Cell Cycle. 2016;15:1531–7.
Google Scholar
Pawlowski J, Kraft AS. Bax-induced apoptotic cell death. Proc Natl Acad Sci USA. 2000;97:529–31.
Google Scholar
Thapa R, Gupta G, Bhat AA, Almalki WH, Alzarea SI, Kazmi I, et al. A review of glycogen synthase kinase-3 (GSK3) inhibitors for cancers therapies. Int J Biol Macromol. 2023;253:127375.
Google Scholar
Marchand B, Arsenault D, Raymond-Fleury A, Boisvert FM, Boucher MJ. Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells. J Biol Chem. 2015;290:5592–605.
Google Scholar
Kuroki H, Anraku T, Kazama A, Bilim V, Tasaki M, Schmitt D, et al. 9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer. Sci Rep. 2019;9:19977.
Google Scholar
Dow LE, O’Rourke KP, Simon J, Tschaharganeh DF, van Es JH, Clevers H, et al. Apc restoration promotes cellular differentiation and reestablishes Crypt homeostasis in colorectal cancer. Cell. 2015;161:1539–52.
Google Scholar
Dias MH, Friskes A, Wang S, Fernandes Neto JM, van Gemert F, Mourragui S, et al. Paradoxical activation of oncogenic signaling as a cancer treatment strategy. Cancer Discov. 2024;14:1276–301.
Google Scholar
Dias MH, Papagianni C, Bernards R. The case for therapeutic overactivation of oncogenic signaling as a potential cancer treatment strategy. Cancer Cell. 2024;42:919–22.
Google Scholar
Parker TW, Rudeen AJ, Neufeld KL Oncogenic serine 45-deleted beta-catenin remains susceptible to Wnt stimulation and APC regulation in human colonocytes. Cancers. 2020;12;2114.
Albuquerque C, Breukel C, van der Luijt R, Fidalgo P, Lage P, Slors FJ, et al. The ‘just-right’ signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet. 2002;11:1549–60.
Google Scholar
da Costa A, Chowdhury D, Shapiro GI, D’Andrea AD, Konstantinopoulos PA. Targeting replication stress in cancer therapy. Nat Rev Drug Discov. 2023;22:38–58.
Google Scholar
Gaillard H, Garcia-Muse T, Aguilera A. Replication stress and cancer. Nat Rev Cancer. 2015;15:276–89.
Google Scholar
Chen X, Cubillos-Ruiz JR. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer. 2021;21:71–88.
Google Scholar
O’Malley J, Kumar R, Inigo J, Yadava N, Chandra D. Mitochondrial stress response and cancer. Trends Cancer. 2020;6:688–701.
Google Scholar
Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel?. Nat Rev Cancer. 2014;14:709–21.
Google Scholar
Tian X, Zhang S, Zhou L, Seyhan AA, Hernandez Borrero L, Zhang Y, et al. Targeting the integrated stress response in cancer therapy. Front Pharm. 2021;12:747837.
Google Scholar
Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer. 2003;3:11–22.
Google Scholar
Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, et al. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol. 2002;156:299–313.
Google Scholar
Ferreira A, Manon S, Eyitayo AR, Chaves SR, Corte-Real M, Preto A, et al. Oncogenic KRAS mutations modulate BAX-mediated cell death. Biochim Biophys Acta Mol Cell Res. 2025;1872:119872.
Google Scholar
Aubrey BJ, Kelly GL, Janic A, Herold MJ, Strasser A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?. Cell Death Differ. 2018;25:104–13.
Google Scholar
Kim SH, Song Y, Seo HR. GSK-3beta regulates the endothelial-to-mesenchymal transition via reciprocal crosstalk between NSCLC cells and HUVECs in multicellular tumor spheroid models. J Exp Clin Cancer Res. 2019;38:46.
Google Scholar
Nocquet L, Roul J, Lefebvre CC, Duarte L, Campone M, Juin PP, et al. Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblasts. Sci Rep. 2024;14:14177.
Google Scholar
Frederick DT, Salas Fragomeni RA, Schalck A, Ferreiro-Neira I, Hoff T, Cooper ZA, et al. Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics. PLoS One. 2014;9:e101286.
Google Scholar
Lin X, Morgan-Lappe S, Huang X, Li L, Zakula DM, Vernetti LA, et al. Seed’ analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737. Oncogene. 2007;26:3972–9.
Google Scholar
Opydo M, Mlyczynska A, Mlyczynska E, Rak A, Kolaczkowska E synergistic action of MCL-1 inhibitor with BCL-2/BCL-XL or MAPK pathway inhibitors enhances acute myeloid leukemia cell apoptosis and differentiation. Int J Mol Sci. 2023;24.
Cantoria MJ, Alizadeh E, Ravi J, Varghese RP, Bunnag N, Pond KW, et al. Feedback in the beta-catenin destruction complex imparts bistability and cellular memory. Proc Natl Acad Sci USA. 2023;120:e2208787120.
Google Scholar
Li C, Furth EE, Rustgi AK, Klein PS When you come to a fork in the road, take it: Wnt signaling activates multiple pathways through the APC/Axin/GSK-3 complex. Cells. 2023;12.
Chang L, Jung NY, Atari A, Rodriguez DJ, Kesar D, Song TY, et al. Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalities. Nat Genet. 2023;55:1709–20.
Google Scholar
link